Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis

Fig. 5

Functional evaluation and validation of the gene signature. A, E, I. Patient distribution based on the risk score. B, F, J. Distribution of the patient survival times based on the risk score. C, G, K Survival analysis between the high and low-risk groups. D, H, L. The ROC curves verified the prognostic value of the gene signature. M. The alluvial map shows that the immunity_L group was more related to the low-risk group

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us